Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03357757
Title Avelumab With Valproic Acid in Virus-associated Cancer (LATENT)
Acronym LATENT
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AHS Cancer Control Alberta
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field